Country/Region: China State/Province: Hubei
Main Products: Pharmaceutical Intermediates
Business Type: Manufacturer, Buying House
Year Established: 2010
Employees: 501 - 1000 People
Plant Area: Above 100,000 square meters
Main Markets: South America 10% Africa 9% Eastern Asia 12% Domestic Market 9% North America 8% Eastern Europe 12% Southern Europe 8% Mid East 9% Northern Europe 10% Oceania 13%
Trade Capacity: FOB, EXW, DAF
Contract Manufacturing: OEM Service Offered Design Service Offered
Nearest Port: Wuhan
Annual Revenue: US$5 Million - US$10 Million
Total Revenue: US$2.5 Million - US$5 Million
Export Revenue: Below US$1 Million
Annual Output: US$10 Million - US$50 Million
Registered Capital: US$10 Million - US$50 Million
Export Percentage: 81% - 90%
Payment Modes: USD, EUR, GBP
Lead Time: 27 days
Import/Export Mode: LLC (Limited Liability Corp)